{
    "Trade/Device Name(s)": [
        "Element V Blood Glucose Monitoring System",
        "Element M V Blood Glucose Monitoring System",
        "Element VBlood Glucose Monitoring System"
    ],
    "Submitter Information": "Infopia Co., Ltd.",
    "510(k) Number": "K132406",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103021"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "March 10, 2014",
    "Summary Letter Received Date": "March 14, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Quality control material (assayed and based)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Element V meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancing Device"
    ],
    "Document Summary": "FDA 510(k) summary for Element V Blood Glucose Monitoring System for quantitative glucose measurement in fresh capillary whole blood using electrochemical technology",
    "Indications for Use Summary": "Intended for the quantitative measurement of glucose in fresh capillary whole blood from various body sites for single patient home use as an aid to monitor the effectiveness of diabetes control, not for diagnosis or screening or neonatal use",
    "fda_folder": "Clinical Chemistry"
}